4 collaborations in 1 year!
How many collaborations were done in the CNS delivery space these last 12 months?
we're on to something and shire, if you don't get off your high horse, you're going to lose this!
i love it!!!
Bioasis enters research agreement with UCBTicker Symbol: C:BTI
Bioasis enters research agreement with UCB
Bioasis Technologies Inc (C:BTI) Shares Issued 39,400,577Last Close 11/30/2012 $1.83Monday December 03 2012 - News Release
Mr. Rob Hutchison reports
BIOASIS ENTERS INTO A RESEARCH COLLABORATION AGREEMENT WITH UCB
Bioasis Technologies Inc. has entered into a research collaboration agreement with UCB, based in Brussels, Belgium, to evaluate Bioasis's Transcend technology in the area of the delivery of therapeutic compounds to the brain. In connection with this agreement, biOasis will conduct certain experiments to provide UCB with confirmation of the Transcend technology as it relates to the delivery of therapeutic compounds owned by UCB to the CNS.
"UCB is a highly respected biopharmaceutical company with a broad global presence and a deep pipeline. We're very pleased to be commencing this collaboration with UCB whom we believe have some tremendous targets for our Transcend vector," said Rob Hutchison, CEO. "The interest from within the industry on our Transcend technology is clearly widening, and this agreement with UCB is a prime example of that. The work will start over the next few months and carry into the New Year. We are looking forward to working with the UCB scientists to successfully achieve the objectives we have set out in agreement."
Financial Terms were not disclosed.
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 8,000 people in about 40 countries, the company generated revenue of EUR 3.2 billion in 2011. UCB is listed on Euronext Brussels (symbol: UCB).
the often imitated, never duplicated..........